Clinical Trials Directory

Trials / Unknown

UnknownNCT05054283

Baseline Blood Indices and Prolonged Length of Hospital Stay

Baseline Blood Indices as a Marker for Prolonged Length of Hospital Stay in Diabetic Older Patients With Mild or Moderate Covid-19 Infection

Status
Unknown
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
Gulhane Training and Research Hospital · Other Government
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

During a pandemic, length of hospital stay (LOS) is critical to managing high patient volumes and preserves access to care related to non-COVID-19 for maintaining the healthcare system. Moreover, identification of prolonged hospital stay may allow physicians to reevaluate critical patients, focused delivery of specific interventions, and improve the efficiency of hospital care. Furthermore, in previous recent studies, attention has been paid to patients with diabetes and COVID-19 infection may require a prolonged LOS. However, there is little evidence on prognostic factors associated with an extension of hospitalization in mild or moderate illness due to COVID-19 infection. Therefore, it is crucial to determine the most vulnerable patients with diabetes mellitus even if they have a non-severe COVID-19 infection during the pandemic. We hypothesize that the clinically relevant inflammatory parameters may have an impact on LOS in older adults with diabetes and non-severe COVID-19 infection. Therefore, we aim to investigate whether baseline inflammatory parameters on admission hospitals as possible predictors of prolonged LOS in older adults with diabetes and non-severe COVID-19 infection during the pandemic.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTInflamatory biomarkerslaboratuary parameters of within 24 hours of admission (levels of white blood cell (WBC), lymphocyte neutrophil, hemoglobin (Hb), platelet, fasting glucose, glycated hemoglobin, aspartate aminotransferase (AST) , c-reactive protein (CRP), ferritin, and procalcitonin) were recorded from medical records and collected by two trained fellow geriatricians.

Timeline

Start date
2021-10-01
Primary completion
2021-11-01
Completion
2021-12-01
First posted
2021-09-23
Last updated
2021-09-23

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05054283. Inclusion in this directory is not an endorsement.

Baseline Blood Indices and Prolonged Length of Hospital Stay (NCT05054283) · Clinical Trials Directory